enzymatica interim report january march 2016 | 1...2016/04/18  · enzymatica interim report...

8
ENZYMATICA INTERIM REPORT JANUARY–MARCH 2016 | 1

Upload: others

Post on 29-Sep-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ENZYMATICA INTERIM REPORT JANUARY MARCH 2016 | 1...2016/04/18  · ENZYMATICA INTERIM REPORT JANUARY–MARCH 2016 | 8 All amounts in SEK thousand Jan-Mar 2016 Jan- Mar 2015 Jan-Dec

E NZ YM AT I C A I N T E R I M R E PO RT J AN UARY –MA RCH 2 0 1 6 | 1

Page 2: ENZYMATICA INTERIM REPORT JANUARY MARCH 2016 | 1...2016/04/18  · ENZYMATICA INTERIM REPORT JANUARY–MARCH 2016 | 8 All amounts in SEK thousand Jan-Mar 2016 Jan- Mar 2015 Jan-Dec

E NZ YM AT I C A I N T E R I M R E PO RT J AN UARY –MA RCH 2 0 1 6 | 2

Page 3: ENZYMATICA INTERIM REPORT JANUARY MARCH 2016 | 1...2016/04/18  · ENZYMATICA INTERIM REPORT JANUARY–MARCH 2016 | 8 All amounts in SEK thousand Jan-Mar 2016 Jan- Mar 2015 Jan-Dec

E NZ YM AT I C A I N T E R I M R E PO RT J AN UARY –MA RCH 2 0 1 6 | 3

Page 4: ENZYMATICA INTERIM REPORT JANUARY MARCH 2016 | 1...2016/04/18  · ENZYMATICA INTERIM REPORT JANUARY–MARCH 2016 | 8 All amounts in SEK thousand Jan-Mar 2016 Jan- Mar 2015 Jan-Dec

E NZ YM AT I C A I N T E R I M R E PO RT J AN UARY –MA RCH 2 0 1 6 | 4

Page 5: ENZYMATICA INTERIM REPORT JANUARY MARCH 2016 | 1...2016/04/18  · ENZYMATICA INTERIM REPORT JANUARY–MARCH 2016 | 8 All amounts in SEK thousand Jan-Mar 2016 Jan- Mar 2015 Jan-Dec

E NZ YM AT I C A I N T E R I M R E PO RT J AN UARY –MA RCH 2 0 1 6 | 5

Page 6: ENZYMATICA INTERIM REPORT JANUARY MARCH 2016 | 1...2016/04/18  · ENZYMATICA INTERIM REPORT JANUARY–MARCH 2016 | 8 All amounts in SEK thousand Jan-Mar 2016 Jan- Mar 2015 Jan-Dec

E NZ YM AT I C A I N T E R I M R E PO RT J AN UARY –MA RCH 2 0 1 6 | 6

All amounts in SEK thousand Jan-Mar 2016 Jan- Mar 2015 Jan-Dec 2015

Operating income

Net sales 8 412 6 961 27 912

Cost of goods sold -3 291 -1 957 -8 486

Gross profit 5 121 5 004 19 426

Sales & Marketing expenses -6 830 -8 465 -31 203

Administrative expenses -4 354 -3 948 -20 906

Research and development costs -1 848 -2 859 -10 898

Other operating income 156 - 9

Capitalized development expenditure 46 1 196 3 054

Operating profit/loss -7 709 -9 072 -40 518

Profit/loss from financial itemsInterest income and similar profit/loss items - 105 133

Interest expenses and similar profit/loss items -390 -41 -445

Profit/loss after financial items -8 099 -9 008 -40 830

Tax expenses - - -

Profit/loss for the period -8 099 -9 008 -40 830

Other comprehensive income:

Total other comprehensive income, net of tax 0 0 0

Total comprehensive income for the period -8 099 -9 008 -40 830

Share attributable to parent company shareholders -8 099 -40 830

-9008

Per share data Jan-Mar 2016 Jan-Mar 2015 Jan-Dec 2015

Earnings per share, SEK (basic and diluted) -0,32 -0,36 -1,64

Equity per share, SEK 0,56 2,14 0,88

Equity-asset ratio, % 34% 88% 50%

Number of outstanding shares 24 961 438 24 961 438 24 961 438

Average number of outstanding shares (basic and diluted) 24 961 438 24 961 438 24 961 438

Definitions of financial ratios

Earnings per share. Profit/loss for the period divided by average

weighted number of shares

Equity-asset ratio. Equity divided by total assets.

Equity per share. Equity divided by number of shares at the end of the

period.

All amounts in SEK thousand Q1 2016 Q4 2015 Q3 2015 Q2 2015 Q1 2015

Net sales 8 412 11 052 6 813 3 086 6 961

Gross profit/loss 5 121 7 190 4 579 2 653 5 004

Gross margin in % 61% 65% 67% 86% 72%

Overhead costs -13 032 -18 324 -15 442 -13 597 -15 272

Operating profit/loss -7 709 -11 134 -9 869 -10 441 -9 072

Profit/loss for the period -8 099 -11 203 -10 134 -10 485 -9 008

Cash flow -866 -1 611 -13 762 -8 400 -6 082

Page 7: ENZYMATICA INTERIM REPORT JANUARY MARCH 2016 | 1...2016/04/18  · ENZYMATICA INTERIM REPORT JANUARY–MARCH 2016 | 8 All amounts in SEK thousand Jan-Mar 2016 Jan- Mar 2015 Jan-Dec

E NZ YM AT I C A I N T E R I M R E PO RT J AN UARY –MA RCH 2 0 1 6 | 7

All amounts in SEK thousand 2016-03-31 2015-03-31 2015-12-31

Assets

Intangible assets 13 683 12 344 13 776

Property, plant & equipment 244 317 276

Inventories 9 984 9 988 11 410

Trade receivables 8 194 3 716 9 495

Other receivables 1 407 2 315 830

Cash and cash equivalents 7 199 31 838 8 065

Total assets 40 711 60 518 43 852

Equity and liabilities

Equity 13 886 53 417 21 985

Current interest-bearing liabilities 15 112 - 10 939

Trade payables 7 173 3 759 5 980

Other liabilities 4 540 3 342 4 948

Total equity and liabilities 40 711 60 518 43 852

All amounts in SEK thousand 2016-03-31 2015-03-31 2015-12-31

Opening balance 21 985 62 425 62 425

Effect of employee share ownership plan - - 390

Profit/loss for the period -8 099 -9 008 -40 830

Other comprehensive income for the period - - -

Closing balance 13 886 53 417 21 985

All amounts in SEK thousand Jan-Mar 2016 Jan- Mar 2015 Jan-Dec 2015

Profit/loss after financial items -8 099 -9 008 -40 830

Adjustments for non-cash items 694 55 1 550

Tax paid - - -

Cash flow from operating activities before changes in working

capital -7 405 -8 953 -39 280

Changes in working capital 2 399 4 109 1 632

Cash flow from operating activities -5 006 -4 844 -37 648

Capitalization of development expenditure -45 -1 196 -3 053

Acquisition/disposal of property, plant & equipment 12 -42 -93

Cash flow from investing activities -33 -1 238 -3 146

Transaction costs attributable to new share issue - - -

Change in bank overdraft facilities 4 173 - 10 939

Cash flow from financing activities 4 173 0 10 939

Total cash flow for the period -866 -6 082 -29 855

Cash and cash equivalents at start of period 8 065 37 920 37 920

Cash and cash equivalents at end of period 7 199 31 838 8 065

Page 8: ENZYMATICA INTERIM REPORT JANUARY MARCH 2016 | 1...2016/04/18  · ENZYMATICA INTERIM REPORT JANUARY–MARCH 2016 | 8 All amounts in SEK thousand Jan-Mar 2016 Jan- Mar 2015 Jan-Dec

E NZ YM AT I C A I N T E R I M R E PO RT J AN UARY –MA RCH 2 0 1 6 | 8

All amounts in SEK thousand Jan-Mar 2016 Jan- Mar 2015 Jan-Dec 2015

Operating income

Net sales 8 412 6 961 27 912

Cost of goods sold -3 291 -1 957 -8 486

Gross profit 5 121 5 004 19 426

Sales & Marketing expenses -6 830 -8 465 -31 203Administrative expenses -4 354 -3 948 -20 372Research and development costs -1 848 -2 859 -10 898

Other operating income 156 - 9

Capitalized development expenditure 46 1 196 3 054

Operating profit/loss -7 709 -9 072 -39 984

Profit/loss from financial items

Interest income and similar profit/loss items - 83 117

Interest expenses and similar profit/loss items -390 -41 -447

Profit/loss after financial items -8 099 -9 030 -40 314

Tax expenses - - -

Profit/loss for the period -8 099 -9 030 -40 314

All amounts in SEK thousand Jan-Mar 2016 Jan- Mar 2015 Jan-Dec 2015

Profit/loss for the period -8 099 -9 030 -40 314

Other comprehensive income: - - -

Total other comprehensive income, net of tax: 0 0 0

Total comprehensive income for the period -8 099 -9 030 -40 314

All amounts in SEK thousand 2016-03-31 2015-03-31 2015-12-31

Assets

Intangible assets 13 683 12 344 13 776

Property, plant & equipment 244 317 276

Financial assets 111 111 111

Inventories 9 984 9 988 11 410

Trade receivables 8 194 3 716 9 495

Receivables from group companies - 5 000 -

Other receivables 1 938 2 283 1 362

Cash and bank balances 7 122 26 786 7 988

Total assets 41 276 60 545 44 418

Equity and liabilities

Equity 14 270 53 264 22 370

Current interest-bearing liabilities 15 112 - 10 939

Liabilities to group companies 191 191 191

Trade payables 7 173 3 758 5 980

Other liabilities 4 530 3 332 4 938

Total equity and liabilities 41 276 60 545 44 418